Literature DB >> 33966395

Poor sleep quality and its related risk factors among university students.

Xiaohong Liu1, Lin Lang2, Rui Wang3, Wangyang Chen1, Xiaohua Ren1, Yi Lin1, Guanqing Chen1, Chenchen Pan1, Wenying Zhao1, Tinghui Li1, Chunlei Han4, Lianping He1, Yuanlong Gu5.   

Abstract

BACKGROUND: Poor sleep quality is a major health problem worldwide. In universities, poor sleep quality can effect student's ability to study and have a serious impact on their psychological and physical well-being. The aim of this study was to explore the quality of sleep among university students and identify risk factors associated with poor sleep quality.
METHODS: A cross-sectional study was conducted and the Pittsburgh sleep quality index scale was used to measure sleep quality. The overall score of the PSQI ranges from 0 to 21, with a score of 4 or less indicating good sleep quality, a score of 5-10 indicating fairly good sleep quality, 11-15 indicating fairly bad sleep quality, and a score of 16-21 indicating poor sleep quality.
RESULTS: A total of 1,317 subjects were enrolled in the study. Most subjects were female (64.6%) and rural based (69.2%). Low intensity sports activity more than once per week was reported by 81.9% of subjects and 59.8% reported they participated in high-intensity sports more than once a week. In addition, 72.8% of subjects took a nap more than three times per week.
CONCLUSIONS: We found that physical activity and taking a nap may be important factors in improving sleep quality and preventing sleep disorders among university students.

Entities:  

Keywords:  Exercise; risk factors; sleep; students; universities

Mesh:

Year:  2021        PMID: 33966395     DOI: 10.21037/apm-21-472

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  2 in total

1.  LY395756 promotes NR2B expression via activation of AKT/CREB signaling in the juvenile methylazoxymethanol mice model of schizophrenia.

Authors:  Meng-Lin Li; Yuan Peng; Ying An; Guo-Yan Li; Yue Lan
Journal:  Brain Behav       Date:  2022-01-13       Impact factor: 2.708

2.  Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder.

Authors:  Junliang Zhu; Jianhuang Chen; Kaixue Zhang
Journal:  Brain Behav       Date:  2022-07-05       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.